Research programme: anti-inflammatories - Endocyte

Drug Profile

Research programme: anti-inflammatories - Endocyte

Alternative Names: EC 1669; EC-0565; EC-0746; EC-2319

Latest Information Update: 01 May 2013

Price : $50

At a glance

  • Originator Endocyte
  • Class Drug conjugates; Small molecules
  • Mechanism of Action Folate receptor 1 antagonists; Macrophage inhibitors; MTOR protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Inflammation
  • Research Osteoarthritis

Most Recent Events

  • 10 Mar 2017 Endocyte announces intention to submit IND application in 2018
  • 25 Apr 2013 Early research in Osteoarthritis in USA (unspecified route)
  • 24 Feb 2011 Preclinical trials in Inflammation in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top